Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma.

Chenyang Zhan,David Ruohoniemi,Krishna P Shanbhogue,Jason Wei,Theodore H Welling,Ping Gu,James S Park,Nabil N Dagher,Bedros Taslakian,Ryan M Hickey

Journal of Vascular and Interventional Radiology（2020）

引用 75|浏览18

暂无评分

摘要

Radioembolization combined with checkpoint inhibitor immunotherapy in cases of HCC appears to be safe and causes limited treatment-related toxicity. Future prospective studies are needed to identify the optimal combination treatment protocols and evaluate the efficacy of combination therapy.

查看译文

关键词

HCC,OS,PFS,TTP

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要